HIGHLIGHTS
- who: Yixiang Zhan from the South, China have published the research work: Case report: Camrelizumab associated with central retinal vein occlusion, in the Journal: (JOURNAL)
- what: The authors report a case of camrelizumab-induced central retinal vein occlusion during the treatment of SCLC, a severe ocular irAE associated with PD-1 inhibition.
SUMMARY
Case description Immune checkpoint inhibitors (ICIs), particularly programmed cell death 1 (PD-1) inhibitors, have dramatically shifted the therapeutic armamentarium and outcomes of patients with cancers. The number of reported immunerelated adverse events (irAEs) has increased in tandem . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.